文献速递消化道肿瘤放疗胸部肿瘤放疗姑息放疗与转移瘤

倾听黑人患者声音:影响癌症患者参与临床试验决策的因素

Centering Black Voices: Factors Influencing a Cancer Patient's Decision to Join a Clinical Trial.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2026-09-25

该横断面描述性研究纳入172例完成根治性放疗的消化道、胸部、妇科及头颈部恶性肿瘤患者,评估影响黑人患者参与临床试验的心理社会因素。黑人患者较非黑人患者更少已婚、收入更低,虽受邀参加试验比例无差异,但参与意愿更低;宗教信念和信任问题影响决策。

要点

  • 黑人患者参与临床试验意愿显著低于非黑人患者(17.1% vs 31.9%,P<.001)。
  • 动机预测相关性评分较高者参与试验可能性高2.5倍(P=.031)。
  • 宗教预测相关性评分较高者参与试验可能性低44%(P=.036)。

核心结论

  • 精神信仰可能在黑人患者临床试验决策中起关键作用,且黑人患者对临床研究存在潜在不信任,尽管大多数人信任其癌症治疗团队。

研究设计与样本

  • 横断面描述性研究,采用改编自2项经过验证的调查问卷,于2023年10月至2024年2月纳入247例合格患者中的172例完成根治性放疗的消化道、胸部、妇科及头颈部恶性肿瘤患者(调查参与率70%)。

主要发现

  • 黑人患者占参与者的24%(n=42),较非黑人患者更少已婚(16.7% vs 68.8%,P<.001)、更少拥有学士学位(9.5% vs 24.2%,P=.048)或研究生学位(2.4% vs 14.1%,P=.046),中位收入更低(69,318美元 vs 106,823美元,P<.001)。
  • 两组被邀请参加实际临床试验的比例无显著差异(黑人 vs 非黑人:17.9% vs 21.7%,P=NS),但黑人患者报告愿意参与的比例更低(17.1% vs 31.9%,P<.001)。
  • 动机预测相关性评分较高的患者参与试验的可能性高2.5倍(P=.031),而宗教预测相关性评分较高的患者参与可能性低44%(P=.036)。
  • 黑人患者较非黑人患者更倾向于同意疾病/死亡由上帝旨意决定(48% vs 17.3%,P=.024)以及上帝决定健康而非研究(55.1% vs 16.5%,P<.001)。
  • 18%的黑人患者同意研究伤害少数族裔(非黑人3.6%,P=.001);黑人患者认为参与研究对自己(11.8% vs 3.2%,P=.01)或社区(25.1% vs 5.3%,P=.006)没有益处。

关键数值与推荐

  • 至少90%的两组参与者信任其癌症医生。

临床怎么用

  • 针对黑人患者设计临床试验招募策略时,应考虑其精神信仰和对研究的不信任,并强调试验对个人和社区的潜在获益。

局限性

  • 研究为横断面描述性设计,仅纳入完成根治性放疗的特定瘤种患者,结果可能不适用于其他治疗阶段或瘤种。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The enrollment of Black patients (BPs) in cancer-related clinical trials has recently declined, and its etiology remains poorly understood. We aim to characterize psychosocial factors that influence patients with curative gastrointestinal, thoracic, gynecologic, and head and neck malignancies when enrolling in a research trial, to improve recruitment and retention of BPs. METHODS AND MATERIALS: We conducted a cross-sectional, descriptive study using a questionnaire adapted from 2 validated surveys for patients who completed definitive radiation treatment for the aforementioned malignancies. Chi-square and Mann-Whitney U tests assessed differences between the populations. RESULTS: From October 2023 to February 2024, 172 of 247 eligible patients agreed to participate (survey participation 70%). BP comprised 24% of patients who participated (n = 42). BPs were less likely to be married (16.7% vs 68.8%; P < .001), have a bachelor's (9.5% vs 24.2%; P = .048), or graduate degree (2.4% vs 14.1%; P =.046), and a lower median income ($69,318 vs $106,823; P < .001) when compared with non-Black patients (NBPs). Both groups were equally invited to an actual clinical trial (BPs vs NBPs; 17.9% vs 21.7%; P = NS); however, fewer BP reported that they would participate (17.1% vs 31.9%; P < .001). Patients with a higher motivation prediction relevance score were 2.5 times more likely to join a trial (P = .031), whereas those with a higher religious prediction relevance score were 44% less likely to join (P = .036). Compared with NBPs, BPs were more apt to agree that illness/death is determined by God's will (48% vs 17.3%; P = .024) and that God determines wellness, not research (55.1% vs 16.5%; P < .001). Eighteen percent of BP agreed that research harms minorities versus 3.6% of NBP (P = .001). BPs felt that there was nothing for them (11.8% vs 3.2%; P = .01) or their community (25.1% vs 5.3%; P = .006) to gain by participating in research when compared with NBPs. At least 90% of participants in both groups trusted their cancer doctors. CONCLUSIONS: Spiritual beliefs may play a key role in clinical trial decision-making among BPs. Although most patients trust their cancer care team, there remains underlying distrust in clinical research among BPs.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Gomez C, Eggleston C, Ferris M, et al. Centering Black Voices: Factors Influencing a Cancer Patient's Decision to Join a Clinical Trial. Int J Radiat Oncol Biol Phys. 2026. PMID: 42790602. doi:10.1016/j.ijrobp.2026.08.078

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。